ThePharmaFacts

       Zydus Healthcare launched its Dapagliflozin in two variants, 10mg and 5mg with   Rs 17 and Rs 14 respectively.    New Delhi: Leading Medicine Manufacturing company Zydus launches Dapagliflozin tablets, across the country with the brand name “Dapaglyn” at a very pocket-friendly cost.                                                   This medicine daily prescribed as an adjuvant to diet and exercise, and the main purpose to control the glycemic level in adults suffering from type 2 diabetes mellitus, Zydus healthcare explained.           Zydus launched this anti-diabetic medicine in two strengths of 10mg and 5mg with price Rs. 17 and Rs 14 respectively, which priced at ⅓ cost than currently available medicine. Due to this reason, this therapy becomes very economical, easily accessible, ...

       The Supreme Court recently ruled that drug inspectors can carry out an investigation and file a first information report (FIR) related to cognizable offenses which are specified as under chapter IV of the Drug and Cosmetics Act 1940. Chapter IV of the Drugs and Cosmetics Act 1940, deals with the manufacture, sale, and distribution of drugs and cosmetics activities.      Section 22(1)(d) of the Act, which deals with the powers of the ‘Inspector’, inter alia, enables the inspector to exercise such other powers as may be necessary for carrying out the purpose of Chapter IV or any Rules made thereunder. A police officer can register an FIR only if a cognizable offense, other than an offense falling under Chapter IV of the Act, is also made out. As far as FIRs that have already been filed are concerned, further investigation cannot be done by the Police officer.      The recent judgment of the Supreme Court concluded that for offenses...